|
11 Companies |
|
15 Products |
|
15 Products |
|
21 Mechanisms of Action |
|
2 Trials |
|
414 News |
|
| 123456789» |
- | Trial completion date, Trial primary completion date: Atypical Fracture Cohort Study (clinicaltrials.gov) - May 23, 2023
P=N/A, N=300, Recruiting, Sponsor: University Health Network, Toronto
Trial completion date: Dec 2022 --> Dec 2026 | Trial primary completion date: Dec 2020 --> Dec 2025
- | tranexamic acid oral / Generic mfg.
Phase classification, Enrollment change, Trial completion date: Tranexamic Acid Use in Acute Hip Fractures (clinicaltrials.gov) - Feb 21, 2023
P4, N=113, Completed, Sponsor: Carilion Clinic
Trial completion date: Dec 2022 --> Dec 2026 | Trial primary completion date: Dec 2020 --> Dec 2025 Phase classification: P=N/A --> P4 | N=400 --> 113 | Trial completion date: Aug 2017 --> May 2022
- | Trial completion, Enrollment change: Pediatric Femur Research Project (clinicaltrials.gov) - Apr 26, 2019
P=N/A, N=48, Completed, Sponsor: Washington University School of Medicine
Phase classification: P=N/A --> P4 | N=400 --> 113 | Trial completion date: Aug 2017 --> May 2022 Active, not recruiting --> Completed | N=145 --> 48
- | NN1213 / Novo Nordisk
Trial completion: Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=738, Completed, Sponsor: Henry Ford Health System
Active, not recruiting --> Completed | N=145 --> 48 Active, not recruiting --> Completed
- | Enrollment change, Trial completion date, Trial initiation date, Trial termination, Trial primary completion date: Trigen InterTAN vs Sliding Hip Screw RCT (clinicaltrials.gov) - Mar 29, 2019
P=N/A, N=34, Terminated, Sponsor: Smith & Nephew Orthopaedics AG
Active, not recruiting --> Completed N=180 --> 34 | Trial completion date: Mar 2019 --> Sep 2017 | Initiation date: Oct 2016 --> Sep 2017 | Recruiting --> Terminated | Trial primary completion date: Feb 2019 --> Sep 2017; Low recruitment
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date, Surgery: Effect of Anesthesia Technique on Outcome After Hip Fracture Surgery in Elderly Adult Patients (clinicaltrials.gov) - Mar 19, 2019
P=N/A, N=186, Completed, Sponsor: Yonsei University
N=180 --> 34 | Trial completion date: Mar 2019 --> Sep 2017 | Initiation date: Oct 2016 --> Sep 2017 | Recruiting --> Terminated | Trial primary completion date: Feb 2019 --> Sep 2017; Low recruitment Recruiting --> Completed | Trial completion date: Mar 2017 --> Jan 2019 | Trial primary completion date: Mar 2017 --> Jan 2019
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Exome Sequencing for Atypical Femoral Fractures (clinicaltrials.gov) - Dec 31, 2018
P=N/A, N=38, Completed, Sponsor: Washington University School of Medicine
Recruiting --> Completed | Trial completion date: Mar 2017 --> Jan 2019 | Trial primary completion date: Mar 2017 --> Jan 2019 Enrolling by invitation --> Completed | Trial completion date: Jun 2018 --> Mar 2018 | Trial primary completion date: Jun 2018 --> Mar 2018
- | NN1213 / Novo Nordisk
Phase classification: TUFFEN: Trial of Ultrasound Guided Femoral Nerve Block on Isolated Femur Fracture Using Echo Friendly Needles (clinicaltrials.gov) - Dec 7, 2018
P4, N=12, Terminated, Sponsor: The University of Texas Health Science Center, Houston
Enrolling by invitation --> Completed | Trial completion date: Jun 2018 --> Mar 2018 | Trial primary completion date: Jun 2018 --> Mar 2018 Phase classification: P=N/A --> P4
- | Enrollment change, Trial completion date, Trial primary completion date: Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures (clinicaltrials.gov) - Nov 30, 2018
P3, N=15, Terminated, Sponsor: Dr. Jeff Yach
Phase classification: P=N/A --> P4 N=126 --> 15 | Trial completion date: Apr 2014 --> Nov 2017 | Trial primary completion date: Apr 2014 --> Nov 2017
- | NN1213 / Novo Nordisk
Enrollment closed, Trial primary completion date: Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy (clinicaltrials.gov) - Aug 2, 2018
P=N/A, N=1000, Active, not recruiting, Sponsor: Henry Ford Health System
N=126 --> 15 | Trial completion date: Apr 2014 --> Nov 2017 | Trial primary completion date: Apr 2014 --> Nov 2017 Recruiting --> Active, not recruiting | Trial primary completion date: May 2018 --> Aug 2018
- | NN1213 / Novo Nordisk
Phase classification, Surgery: A Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia (clinicaltrials.gov) - Jul 30, 2018
P=N/A, N=15, Completed, Sponsor: University of Pennsylvania
Recruiting --> Active, not recruiting | Trial primary completion date: May 2018 --> Aug 2018 Phase classification: P4 --> P=N/A
- | Trial completion date, Trial termination, Trial primary completion date, Surgery: Multi-centre Study to Assess the Long-term Performance of the Deltamotion Cup System in Primary Hip Replacement Surgery (clinicaltrials.gov) - Jul 19, 2018
P4, N=250, Terminated, Sponsor: DePuy International
Phase classification: P4 --> P=N/A Trial completion date: Mar 2024 --> Feb 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Feb 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: ClearNOF: Non Invasive Cardiac Output Monitoring to Guide Goal Directed Fluid Therapy in High Risk Patients Undergoing Urgent Surgical Repair of Proximal Femoral Fractures (clinicaltrials.gov) - Jul 2, 2018
P=N/A, N=240, Completed, Sponsor: York Teaching Hospitals NHS Foundation Trust
Trial completion date: Mar 2024 --> Feb 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Feb 2018 Recruiting --> Completed | Trial completion date: Apr 2017 --> Sep 2017 | Trial primary completion date: Feb 2017 --> Sep 2017
- | NN1213 / Novo Nordisk
Trial completion, Phase classification, Trial completion date, Trial primary completion date: Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium (clinicaltrials.gov) - Jun 20, 2018
P=N/A, N=82, Completed, Sponsor: Konkuk University Medical Center
Recruiting --> Completed | Trial completion date: Apr 2017 --> Sep 2017 | Trial primary completion date: Feb 2017 --> Sep 2017 Recruiting --> Completed | Phase classification: P4 --> PN/A | Trial completion date: Jul 2017 --> Apr 2018 | Trial primary completion date: Jul 2017 --> Apr 2018
- | Trial completion, Surgery, Compliance: ECHONOFII: Trial of Focused Cardiac Ultrasound for Fractured Neck of Femur Surgery (clinicaltrials.gov) - May 2, 2018
P=N/A, N=100, Completed, Sponsor: University of Melbourne
Recruiting --> Completed | Phase classification: P4 --> PN/A | Trial completion date: Jul 2017 --> Apr 2018 | Trial primary completion date: Jul 2017 --> Apr 2018 Active, not recruiting --> Completed
- | Enrollment change, Trial termination: Efficacy Study of Femoral Nerve Block in Children With a Femur Fracture (clinicaltrials.gov) - Mar 31, 2018
P=N/A, N=2, Terminated, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed N=180 --> 2 | Enrolling by invitation --> Terminated; Patients were not willing to be randomized and therefore recruitment could not continue.
- || Trial primary completion date: Trigen InterTAN vs Sliding Hip Screw RCT (clinicaltrials.gov) - Mar 20, 2018
P=N/A, N=180, Recruiting, Sponsor: Smith & Nephew Orthopaedics AG
N=180 --> 2 | Enrolling by invitation --> Terminated; Patients were not willing to be randomized and therefore recruitment could not continue. Trial primary completion date: Feb 2018 --> Feb 2019
- | ropivacaine / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Fascia Iliaca Compartment Block in Acute and Chronic Pain Management in Hip Fracture Patients (clinicaltrials.gov) - Mar 6, 2018
P=N/A, N=198, Completed, Sponsor: Asklepieion Voulas General Hospital
Trial primary completion date: Feb 2018 --> Feb 2019 Active, not recruiting --> Completed | Trial completion date: Sep 2017 --> Jan 2018 | Trial primary completion date: Sep 2017 --> Jan 2018
- ||| Trial completion, Trial completion date, Trial primary completion date: Project JAY HAP Registration Study (clinicaltrials.gov) - Mar 2, 2018
P=N/A, N=134, Completed, Sponsor: Smith & Nephew Orthopaedics (Beijing) Limited
Active, not recruiting --> Completed | Trial completion date: Sep 2017 --> Jan 2018 | Trial primary completion date: Sep 2017 --> Jan 2018 Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Oct 2017 | Trial primary completion date: Nov 2017 --> Oct 2017
- | Trial completion, Trial primary completion date: Validity and Reliability of Thai Version of Barthel Index for Hip Fracture Patients (clinicaltrials.gov) - Feb 22, 2018
P=N/A, N=53, Completed, Sponsor: Mahidol University
Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Oct 2017 | Trial primary completion date: Nov 2017 --> Oct 2017 Recruiting --> Completed | Trial primary completion date: Aug 2017 --> Jun 2016
- | Trial completion, Trial completion date, Trial primary completion date, HEOR: Fast Track Hip Fracture - an Optimized Pathway for Hip Fracture Patients (clinicaltrials.gov) - Feb 5, 2018
P=N/A, N=2495, Completed, Sponsor: University Hospital, Akershus
Recruiting --> Completed | Trial primary completion date: Aug 2017 --> Jun 2016 Active, not recruiting --> Completed | Trial completion date: Sep 2017 --> Sep 2017 | Trial primary completion date: Sep 2017 --> Sep 2017
- | ropivacaine / Generic mfg.
Trial completion, Trial primary completion date: Single Shot Fascia Iliaca Block vs Femoral Nerve Block for Analgesia for Surgical Fixation of Hip Fractures (clinicaltrials.gov) - Jan 25, 2018
P=N/A, N=30, Completed, Sponsor: Changi General Hospital
Active, not recruiting --> Completed | Trial completion date: Sep 2017 --> Sep 2017 | Trial primary completion date: Sep 2017 --> Sep 2017 Recruiting --> Completed | Trial primary completion date: Aug 2015 --> Mar 2015
- | Trial completion, Surgery: The Effect of Femoral Nerve Block on Opioid Requirements After Surgery for a Femur Fracture in Children (clinicaltrials.gov) - Jan 10, 2018
P1, N=25, Completed, Sponsor: University of British Columbia
Recruiting --> Completed | Trial primary completion date: Aug 2015 --> Mar 2015 Terminated --> Completed
- | sevoflurane / Generic mfg.
Trial completion, Enrollment change: Effect of Anesthesia in Fracture Healing (clinicaltrials.gov) - Nov 21, 2017
P4, N=30, Completed, Sponsor: Cukurova University
Terminated --> Completed Recruiting --> Completed | N=40 --> 30
- | Trial primary completion date: Exome Sequencing for Atypical Femoral Fractures (clinicaltrials.gov) - Nov 9, 2017
P=N/A, N=36, Enrolling by invitation, Sponsor: Washington University School of Medicine
Recruiting --> Completed | N=40 --> 30 Trial primary completion date: Apr 2017 --> Jun 2018
- | ropivacaine / Generic mfg.
Trial completion: Perioperative Analgesia by Femoral Perineural Catheter for Femoral Neck Fracture - Study KTcol (clinicaltrials.gov) - Nov 1, 2017
P4, N=60, Completed, Sponsor: University Hospital, Angers
Trial primary completion date: Apr 2017 --> Jun 2018 Recruiting --> Completed
- | Trial completion: MIS-CLAS: Minimal Invasive Anterior Approach Versus Trans-gluteal Approach for Hemi-arthroplasty in Femoral Neck Fractures (clinicaltrials.gov) - Oct 25, 2017
P4, N=190, Completed, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Completed Active, not recruiting --> Completed
- | Enrollment change, Trial primary completion date: European Quality of Care Pathways Study on the Effect of Care Pathways on Interprofessional Teamwork (EQCP-TEAM) (clinicaltrials.gov) - Oct 13, 2017
P=N/A, N=984, Completed, Sponsor: Dr. Kris Vanhaecht
Active, not recruiting --> Completed N=475 --> 984 | Trial primary completion date: Dec 2013 --> Jun 2014
- | Trial completion, Trial primary completion date: European Quality of Care Pathways Study on Proximal Femur Fracture (EQCP-PFF) (clinicaltrials.gov) - Oct 13, 2017
P=N/A, N=514, Completed, Sponsor: European Pathway Association
N=475 --> 984 | Trial primary completion date: Dec 2013 --> Jun 2014 Enrolling by invitation --> Completed | Trial primary completion date: Dec 2011 --> May 2014
- | tranexamic acid oral / Generic mfg.
Trial completion: Tranexamic Acid Use in Acute Hip Fractures (clinicaltrials.gov) - Sep 21, 2017
P=N/A, N=400, Completed, Sponsor: Carilion Clinic
Enrolling by invitation --> Completed | Trial primary completion date: Dec 2011 --> May 2014 Recruiting --> Completed
- Enrollment change, Trial withdrawal: Excia T Cementless EBRA Study (clinicaltrials.gov) - Sep 7, 2017
P=N/A, N=0, Withdrawn, Sponsor: Aesculap AG
Recruiting --> Completed N=100 --> 0 | Not yet recruiting --> Withdrawn
- | ropivacaine / Generic mfg.
Trial completion: Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia (clinicaltrials.gov) - Sep 6, 2017
P=N/A, N=24, Completed, Sponsor: Kuala Lumpur General Hospital
N=100 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed
- | Trial completion: Post-Operative Delirium in Elderly Surgical Patients (clinicaltrials.gov) - Aug 24, 2017
P=N/A, N=200, Completed, Sponsor: Johns Hopkins University
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial primary completion date, HEOR: Fast Track Hip Fracture - an Optimized Pathway for Hip Fracture Patients (clinicaltrials.gov) - Aug 24, 2017
P=N/A, N=2490, Active, not recruiting, Sponsor: University Hospital, Akershus
Active, not recruiting --> Completed Trial primary completion date: May 2017 --> Sep 2017
- | Enrollment change: PERFECTED: Care Delivery in Acute Hospital Settings: an Observational Study (clinicaltrials.gov) - Aug 11, 2017
P=N/A, N=180, Completed, Sponsor: University of East Anglia
Trial primary completion date: May 2017 --> Sep 2017 N=100 --> 180
- | Enrollment change, Trial termination, Trial primary completion date: COL-FOP: Hip Fracture and Patent Foramen Ovale (clinicaltrials.gov) - Aug 9, 2017
P=N/A, N=41, Terminated, Sponsor: Hopital Foch
N=100 --> 180 N=100 --> 41 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Apr 2017; We have discovered a too low prevalence of Patent Foramen Ovale compared to the theoretical % of around 20-25%.
- | Trial completion: Anterolateral Versus Posterolateral Approach to the Fractured Hip Arthroplasty (clinicaltrials.gov) - Aug 2, 2017
P=N/A, N=160, Completed, Sponsor: Sundsvall Hospital
N=100 --> 41 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Apr 2017; We have discovered a too low prevalence of Patent Foramen Ovale compared to the theoretical % of around 20-25%. Active, not recruiting --> Completed
- | sevoflurane / Generic mfg.
Trial primary completion date: Effect of Anesthesia in Fracture Healing (clinicaltrials.gov) - Jul 21, 2017
P4, N=40, Recruiting, Sponsor: Cukurova University
Active, not recruiting --> Completed Trial primary completion date: May 2017 --> Aug 2017
- | ropivacaine / Generic mfg.
Enrollment closed, Enrollment change, Trial primary completion date: Fascia Iliaca Compartment Block in Acute and Chronic Pain Management in Hip Fracture Patients (clinicaltrials.gov) - Jul 5, 2017
P=N/A, N=198, Active, not recruiting, Sponsor: Asklepieion Voulas General Hospital
Trial primary completion date: May 2017 --> Aug 2017 Recruiting --> Active, not recruiting | N=120 --> 198 | Trial primary completion date: May 2017 --> Sep 2017
- | Acetavance (acetaminophen) / Mallinckrodt
Enrollment change, Trial termination, Trial primary completion date: Pain Control in Elderly Hip Fracture Patients: Is Intravenous Acetaminophen Superior to Oral Administration? (clinicaltrials.gov) - Jun 27, 2017
P4, N=1, Terminated, Sponsor: Spectrum Health Hospitals
Recruiting --> Active, not recruiting | N=120 --> 198 | Trial primary completion date: May 2017 --> Sep 2017 N=106 --> 1 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Dec 2016; Proved difficult to consent patient population due to comorbidities
- |||| Trial completion: A Randomised Single Centre Study to Compare the Long-term Wear Characteristics of Marathon (clinicaltrials.gov) - Jun 26, 2017
P4, N=122, Completed, Sponsor: DePuy International
N=106 --> 1 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Dec 2016; Proved difficult to consent patient population due to comorbidities Active, not recruiting --> Completed
- Trial termination: An Electronic Data Capture Study to Assess the Long-term Performance of the DePuy PROXIMA (clinicaltrials.gov) - Jun 26, 2017
P4, N=42, Terminated, Sponsor: DePuy International
Active, not recruiting --> Completed Active, not recruiting --> Terminated; Study terminated early for business reasons
- ||| Enrollment closed, Trial primary completion date, Surgery: Multi-centre Study to Assess the Long-term Performance of the Deltamotion Cup System in Primary Hip Replacement Surgery (clinicaltrials.gov) - Jun 9, 2017
P4, N=250, Active, not recruiting, Sponsor: DePuy International
Active, not recruiting --> Terminated; Study terminated early for business reasons Recruiting --> Active, not recruiting | Trial primary completion date: May 2017 --> Dec 2019
- | Phase classification, HEOR, Surgery: Using Alternative Implants for the Surgical Treatment of Hip Fractures (The FAITH Study) (clinicaltrials.gov) - Apr 27, 2017
P=N/A, N=1079, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting --> Active, not recruiting | Trial primary completion date: May 2017 --> Dec 2019 Phase classification: P3 --> P=N/A
- | Phase classification: Project JAY THA Registration Study (clinicaltrials.gov) - Apr 27, 2017
P=N/A, N=100, Completed, Sponsor: Smith & Nephew Orthopaedics (Beijing) Limited
Phase classification: P3 --> P=N/A Phase classification: P3 --> P=N/A
- || Enrollment closed, Phase classification: Project JAY HAP Registration Study (clinicaltrials.gov) - Apr 27, 2017
P=N/A, N=134, Active, not recruiting, Sponsor: Smith & Nephew Orthopaedics (Beijing) Limited
Phase classification: P3 --> P=N/A Recruiting --> Active, not recruiting | Phase classification: P3 --> PN/A
- | Trial completion: ADhipfract: Alzheimers Disease and Neuromarkers in Patients With Acute Hip Fractures (clinicaltrials.gov) - Apr 26, 2017
P=N/A, N=400, Completed, Sponsor: Sahlgrenska University Hospital, Sweden
Recruiting --> Active, not recruiting | Phase classification: P3 --> PN/A Recruiting --> Completed
- || Trial initiation date: Excia T Cementless EBRA Study (clinicaltrials.gov) - Apr 26, 2017
P=N/A, N=100, Not yet recruiting, Sponsor: Aesculap AG
Recruiting --> Completed Initiation date: Dec 2016 --> Aug 2017
- | Trial completion: Elderly With Hip Fracture and Perioperative Hemoglobin and Perfusion Index Levels (clinicaltrials.gov) - Apr 26, 2017
P=N/A, N=50, Completed, Sponsor: Hvidovre University Hospital
Initiation date: Dec 2016 --> Aug 2017 Not yet recruiting --> Completed
- ||| Trial completion: Intramedullary Nail Versus Sliding Hip Screw Inter-Trochanteric Evaluation (clinicaltrials.gov) - Apr 25, 2017
P=N/A, N=880, Completed, Sponsor: Stryker Trauma GmbH
Not yet recruiting --> Completed Active, not recruiting --> Completed